IRIS
CATALANOTTI, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.543
EU - Europa 3.263
NA - Nord America 2.564
SA - Sud America 527
AF - Africa 124
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.026
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.441
SG - Singapore 1.822
RU - Federazione Russa 1.330
IT - Italia 1.022
CN - Cina 813
BR - Brasile 424
HK - Hong Kong 306
VN - Vietnam 295
DE - Germania 172
UA - Ucraina 160
NL - Olanda 111
FI - Finlandia 108
GB - Regno Unito 87
CA - Canada 77
SE - Svezia 68
IE - Irlanda 52
IN - India 52
FR - Francia 50
AR - Argentina 46
KR - Corea 44
CI - Costa d'Avorio 42
MA - Marocco 37
JP - Giappone 33
MX - Messico 33
TR - Turchia 27
ID - Indonesia 25
ZA - Sudafrica 25
AT - Austria 23
ES - Italia 23
BD - Bangladesh 22
IR - Iran 20
PL - Polonia 17
EC - Ecuador 15
CZ - Repubblica Ceca 14
IQ - Iraq 11
CO - Colombia 10
PK - Pakistan 9
VE - Venezuela 9
MY - Malesia 8
UZ - Uzbekistan 7
CL - Cile 6
PE - Perù 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
BE - Belgio 5
EG - Egitto 5
LT - Lituania 5
TW - Taiwan 5
LU - Lussemburgo 4
UY - Uruguay 4
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
MW - Malawi 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
BH - Bahrain 1
CG - Congo 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GA - Gabon 1
GF - Guiana Francese 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
JM - Giamaica 1
KH - Cambogia 1
MT - Malta 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
RO - Romania 1
RW - Ruanda 1
SD - Sudan 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
Totale 10.024
Salva come PNG Salva come JPEG
Città #
Singapore 836
Chandler 320
Naples 319
Moscow 317
Hong Kong 304
Beijing 269
Ashburn 228
Hefei 197
Santa Clara 126
Jacksonville 117
Ho Chi Minh City 91
Los Angeles 87
Boston 74
Millbury 68
Amsterdam 67
Napoli 64
Princeton 63
Dallas 56
São Paulo 51
Vietri Sul Mare 49
Dong Ket 48
San Jose 48
Nanjing 47
Munich 46
Hanoi 44
Buffalo 43
New York 39
Redondo Beach 37
Seoul 37
Casablanca 31
Nuremberg 29
Ottawa 29
Dearborn 26
Milan 26
Tokyo 26
Des Moines 22
London 20
Montreal 20
Shenyang 20
Wilmington 20
Seattle 19
Torre del Greco 19
Helsinki 18
Lawrence 18
Brooklyn 17
Chicago 17
Nanchang 17
Turku 17
Perugia 16
The Dalles 16
Denver 15
Formia 15
Toronto 15
Warsaw 15
Woodbridge 15
Cercola 14
Frankfurt am Main 14
Hebei 14
Mexico City 14
Tianjin 14
Lappeenranta 13
Rio de Janeiro 13
San Francisco 13
Torre Annunziata 13
Boardman 12
Falkenstein 12
Haiphong 12
Rome 12
Stockholm 12
Atlanta 11
Bari 11
Biên Hòa 11
Johannesburg 11
Kronberg 11
Orem 11
Ankara 10
Ann Arbor 10
Bogor 10
Kochi 10
Norwalk 10
Changsha 9
Chennai 9
Belo Horizonte 8
Langhirano 8
Manchester 8
Poplar 8
Querétaro 8
Thái Nguyên 8
Da Nang 7
Dhaka 7
Ercolano 7
Falls Church 7
Orta di Atella 7
Phoenix 7
Porto Alegre 7
Ribeirão Preto 7
San Giorgio a Cremano 7
Bắc Ninh 6
Cernusco Lombardone 6
Dublin 6
Totale 5.055
Salva come PNG Salva come JPEG
Nome #
Ubiquitylation of BBSome is required for ciliary assembly and signaling 197
3D GRID-based pharmacophore and Metadynamics approaches for the rational design of N-Methyl β-sheet breaker peptides as inhibitors of the Alzheimer's Aβ-amyloid fibrillogenesis 191
Design, Synthesis, and Pharmacological Evaluation of Dual FXR-LIFR Modulators for the Treatment of Liver Fibrosis 164
Natural and semisynthetic bile acids as Leukemia Inhibitory Factor (LIF) receptor antagonists 147
Discovery of a Novel Class of Dual GPBAR1 Agonists-RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders 140
Peptide Nucleic Acids as miRNA Target Protectors for the Treatment of Cystic Fibrosis 139
Discovery of a Potent and Orally Active Dual GPBAR1/CysLT1R Modulator for the Treatment of Metabolic Fatty Liver Disease 138
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 132
Specific Targeting Highly Conserved Residues in the HIV-1 Reverse Transcriptase Primer Grip Region. Design, Synthesis, and Biological Evaluation of Novel, Potent, and Broad Spectrum NNRTIs with Antiviral Activity 130
Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists 130
Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma 128
Hijacking SARS-CoV-2/ACE2 Receptor Interaction by Natural and Semi-synthetic Steroidal Agents Acting on Functional Pockets on the Receptor Binding Domain 125
Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer 122
The TBC1D31/praja2 complex controls primary ciliogenesis through PKA-directed OFD1 ubiquitylation 121
Inibizione selettiva dei sistemi di trasporto neuronale Na+ dipendente dell’acido glutammico (EAAT). Progettazione e sintesi di nuovi potenziali agenti neuroprotettivi. 120
Feedback inhibition of cAMP effector signaling by a chaperone-assisted ubiquitin system 120
Understanding the Aβ(1–42) Fibrillogenesis Inhibition of Novel N-Methyl Beta-sheet Breaker Peptides by Molecular Dynamics Simulations 118
From protein-protein interaction to E2 inhibitors leads: identification of peptide binding of UbcH10 118
Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis 117
MOLECULAR BASIS OF ANTI-INFLAMMATORY POTENTIAL OF BIOACTIVE COMPOUNDS IN FERMENTED-CHICKPEA PUREES 115
Exploitation of a Very Small Peptide Nucleic Acid as a New Inhibitor of miR-509-3p Involved in the Regulation of Cystic Fibrosis Disease-Gene Expression 115
The leukemia inhibitory factor regulates fibroblast growth factor receptor 4 transcription in gastric cancer 114
Full relative stereochemistry assignment and conformational analysis of 13,19-didesmethyl spirolide C via NMR- and Molecular Modeling-based techniques. A step towards the comprehension of spirolide mechanism of action. 111
Discovery of Bile Acid Derivatives as Potent ACE2 Activators by Virtual Screening and Essential Dynamics 111
Discovery of a novel class of profen derivatives as FAAH inhibitors: MD and QM/MM studies of the binding mode and 3D SAR. 110
Synthesis and Biological Evaluation of a New Structural Simplified Analogue of cADPR, a Calcium-Mobilizing Secondary Messenger Firstly Isolated from Sea Urchin Eggs 110
Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma 109
Synthesis, biological evaluation and metadynamics simulations of novel N-methyl β-sheet breaker peptides as inhibitors of Alzheimer's β-amyloid fibrillogenesis 108
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents. 107
Structural Basis for Developing Multitarget Compounds Acting on Cysteinyl Leukotriene Receptor 1 and G-Protein-Coupled Bile Acid Receptor 1 107
A multidisciplinary approach for the investigation of the antimalarial activity of natural endoperoxides 106
Novel propanamides as fatty acid amide hydrolase inhibitors 105
Taxol: a Great Peptido Mimetic Produced byNature 104
cADRP Analogues as Probes for the Cellular Ca2+ Signaling 104
Combined FAAH and COX inhibition by Flurbiprofen amide derivatives for the treatment of pain and inflammation 104
Exploring the fatty acid amide hydrolase and cyclooxygenase inhibitory properties of novel amide derivatives of ibuprofen 104
Development of piperazine-tethered heterodimers as potent antimalarials against chloroquine-resistant P. falciparum strains. Synthesis and molecular modeling 103
Target Protector PNA: a new tool in Cystic Fibrosis treatment 103
Targeting multiple G-quadruplex–forming DNA sequences: Design, biophysical and biological evaluations of indolo-naphthyridine scaffold derivatives 103
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury 102
Synthesis of 5-methylamino-2'-deoxyuridine derivatives. 102
A multidisciplinary approach for the investigation of the antimalarial activity of natural endoperoxides 102
Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin 102
A multidisciplinary approach to study the carboxyl-terminal portion of the excitatory amino acid transporter EAAT2:implications for the design of new neuroprotective agents. 99
2'-Deoxy-8-(propyn-1-yl)adenosine-containing oligonucleotides: effects on stability of duplex and quadruplex structures 99
Discovery of new dual GPBAR1 /RORγt modulators with promising activity in the treatment of inflammation diseases 97
Non-nucleooside HIV-1 reverse transcriptase (RT) inhibitors : Past, present. And future perspectives. 97
Design and pharmacological evaluation of Ibuprofen amides derivatives as dual FAAH/COX inhibitors 97
Exploring Boswellia serrata Triterpenes: A New Frontier in Leukemia Inhibitory Factor Receptor Modulation 96
Insight into the mechanism of the antimalarial action of plakortins, simple 1,2-dioxane antimalarials 96
Interaction of the N-(3-Methylpyridin-2-yl)amide Derivatives of Flurbiprofen and Ibuprofen with FAAH: Enantiomeric Selectivity and Binding Mode 95
Syntheses of [1-15N]-2'-deoxyinosine, [4-15N]-2'-deoxyAICAR, and [1-15N]-2'-deoxyguanosine. 94
Oligonucleotidi contenenti 2’-deossi-8-(1—propinil)-Adenosina: stabilità delle strutture quadruplex. 94
Development of novel and potent atypical antipsychotic agents: from rational design to drug candidates 94
Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors 94
Ligand-based drug repurposing strategy identified SARS-CoV-2 RNA G-quadruplex binders 93
Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2 93
Correction to “Discovery of a Novel Class of Dual GPBAR1 Agonists–RORγt Inverse Agonists for the Treatment of IL-17-Mediated Disorders” 92
Development of potent and selective peripheral 5-HT3 receptor agonists and antagonists, keystones of a new therapeutic strategy to cardiac diseases 91
Molecular Basis for Non-Covalent, Non-Competitive FAAH Inhibition 90
cADPR Analagues as Probes for the Cellular Ca2+ Ions Signaling 89
Development of Molecular Probes for the Identification of Extra Interaction Sites in the Mid-Gorge and Peripheral Sites of Butyrylcholinesterase (BuChE). Rational Design of Novel, Selective, and Highly Potent BuChE Inhibitors 88
“NORTHERN” RIBOSE AND PYROPHOSPHATE MODIFIED cADPR ANALOGUES: A NOVEL CLASS OF POTENTIAL Ca2+ MOBILIZERS 88
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 88
Exploiting extra-interaction sites in the mid-gorge and peripheral site of cholinesterase: rational design of novel, selective, and highly potent inhibitors 87
Homology building, protein-protein docking and MD approach to the simulation of the quaternary complex E1/E2/Ub2. 86
DESIGN, SYNTHESIS AND PHARMACOLOGICAL INVESTIGATION OF NEW FAAH INHIBITORS 86
Circular dichroism and termal melting differentiation of Hoechst 33258 bindings to the curved (A4T4) and non curved (T4A4) DNA sequences. 85
Specific targeting of peripheral serotonin 5-HT(3) receptors. Synthesis, biological investigation, and structure-activity relationships. 84
Derivati 1,2-diossanici di origine marina ad attività antimalarica 84
Derivati 1,2-diossanici di origine marina ad attività antimalarica 83
Exploiting protein fluctuation at human cholinesterase active-sites. New Perspectives 83
Sviluppo di nuovi antipsicotici atipici a struttura Pirrolobenzotiazepinica 83
Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents 83
Synthetic polynucleotides and analogues as models for studies concerning DNA. 82
Investigation of a novel pharmacophore for the development ofinnovative antimalarial agents. 81
Theoretical and experimental structural studies on the carboxyl-terminal portion of the excitatory amino acid transporter EAAT2. Implications for the design of new neuroprotective agents 80
Benzoxepin-Derived Estrogen Receptor Modulators: A Novel Molecular Scaffold for the Estrogen Receptor 80
Assignment of the relative stereochemistry of 13,19-didesmethylspirolide C, a macrocyclic toxin isolated from Adriatic dinoflagellate Alexandrium ostenfeldii, by NMR and molecular modelling-based techniques 80
Sintesi di molecole attive nel trattamento del Cocaine-Craving 79
Sintesi di oligonucleotidi modificati per studi chimico-fisici e biologici. 78
SAR studies for drug-discovery: cADPR analogues for the regulation of Ca2+ concentration in PC12 neuronal cells. 78
MOLECULAR BASIS OF ANTI-INFLAMMATORY POTENTIAL OF BIOACTIVE COMPOUNDS IN FERMENTED-CHICKPEA PUREES 77
GLP-1 Mediates Regulation of Colonic ACE2 Expression by the Bile Acid Receptor GPBAR1 in Inflammation 77
NADD: Nature Aided Drug Discovery 75
Boswellia serrata: a rich source of triterpenes acting as antagonists of the leukemia inhibitory factor receptor 74
Nuovi analoghi omo- ed eterodimerici della Tacrina quali potenti e selettivi inibitori dellAcetilcolinoesterasi e della Butirrilcolinestersi 74
Molecular and Structural Aspects of Clinically Relevant Mutations of SARS-CoV-2 RNA-Dependent RNA Polymerase in Remdesivir-Treated Patients 73
Novel Atypical Antipsychotic Agents: Rational Design, an Efficient Palladium-Catalyzed Route, and Pharmacological Studies 73
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 72
Pyrrolo[1,5]benzoxa(thia)zepines as a New Class of Potent Apoptotic Agents. Biological Studies and Identification of an Intracellular Location of Their Drug Target. 72
Endoperoxide Derivatives from Marine Organisms: 1,2-Dioxanes of the Plakortin Family as Novel Antimalarial Agents. 71
TARGETING BILE ACID RECEPTORS FOR TREATMENT OF INFLAMMATORY AND METABOLIC DISEASES 66
Identification of molecular basis of praja2 and TBC1D31 interaction 64
Pyrrolo[1,3]benzothiazepine-Based Atypical Antipsychotic Agents. Synthesis, Structure-Activity Relationship, Molecular Modeling, and Biological Studies 63
Design and Synthesis of Potent Antimalarial Agents Based on Clotrimazole Scaffold: Exploring an Innovative Pharmacophore. 62
Discovery of Huperzine A-Tacrine Hybrids as Potent Inhibitors of Human Cholinesterases Targeting Their Midgorge Recognition Sites 61
Exploiting Protein Fluctuations at the Active-Site Gorge of Human Cholinesterases: Further Optimization of the Design Strategy to Develop Extremely Potent Inhibitors. 60
Specific Targeting of Acetylcholinesterase and Butyrylcholinesterase Recognition Sites. Rational Design of Novel, Selective, and Highly Potent Cholinesterase Inhibitors. 59
A Rational Approach to the Design of Selective Substrates and Potent Nontransportable Inhibitors of the Excitatory Amino Acid Transporter EAAC1 (EAAT3). New Glutamate and Aspartate Analogues as Potential Neuroprotective Agents 56
Totale 9.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.800
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021233 0 0 0 0 0 0 31 21 35 8 84 54
2021/2022502 10 1 3 5 2 15 7 25 70 55 114 195
2022/2023735 97 58 24 71 86 86 13 68 110 56 55 11
2023/2024597 43 72 62 35 24 40 27 77 16 28 104 69
2024/20253.291 127 181 45 86 71 205 347 226 236 308 1.154 305
2025/20263.881 669 542 720 645 1.037 221 47 0 0 0 0 0
Totale 10.223